{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:35:43Z","timestamp":1789767343890,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSMT-11956\/2021-4"],"award-info":[{"award-number":["MSMT-11956\/2021-4"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019214","name":"l\u00e9ka\u0159sk\u00e1 fakulta Univerzity Karlovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["GA UK 190\/54\/251753"],"award-info":[{"award-number":["GA UK 190\/54\/251753"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"publisher","award":["SVV 260 764"],"award-info":[{"award-number":["SVV 260 764"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/18_046\/0016045"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/18_046\/0016045"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177890","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:27:20Z","timestamp":1751563640000},"page":"177890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effectiveness and safety of the SREBP1\/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression"],"prefix":"10.1016","volume":"1003","author":[{"given":"Mahak","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-4672","authenticated-orcid":false,"given":"Nikolina","family":"Canov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"\u0160opin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-3272","authenticated-orcid":false,"given":"Zuzana","family":"Pavl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Ku\u010dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Vac\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Slana\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177890_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med. : J. Br. Diabetic Assoc."},{"key":"10.1016\/j.ejphar.2025.177890_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223528","article-title":"Obesity-associated insulin resistance adversely affects skin function","volume":"14","author":"Aoki","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177890_bib3","article-title":"Pharmacological effects of mTORC1\/C2 inhibitor in a preclinical model of NASH progression","volume":"167","author":"Arora","year":"2023","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177890_bib4","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1815150116","article-title":"PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin","volume":"116","author":"Besse-Patin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2025.177890_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41389-018-0076-0","article-title":"Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer","volume":"7","author":"Brovkovych","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejphar.2025.177890_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","article-title":"Fatostatin induces ferroptosis through inhibition of the AKT\/mTORC1\/GPX4 signaling pathway in glioblastoma","volume":"14","author":"Cai","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177890_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1476994","article-title":"Effects of celastrol on the heart and liver galaninergic system expression in a mouse model of western-type diet-induced obesity and metabolic dysfunction-associated steatotic liver disease and steatohepatitis","volume":"16","author":"Canov\u00e1","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177890_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.867940","article-title":"Hepatic Stellate cell-immune interactions in NASH","volume":"13","author":"Carter","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.177890_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.lfs.2018.04.022","article-title":"Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis","volume":"203","author":"Chen","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177890_bib10","series-title":"Modulation of Antioxidant Enzyme B166 Isoforms 1 and 5 Expressions by SREBP1-a Links ROS Elimination to Lipid Metabolism in Glioblastoma Cells","author":"Cheung","year":"2023"},{"key":"10.1016\/j.ejphar.2025.177890_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.595371","article-title":"Oxidative stress in non-alcoholic fatty liver disease. An updated mini review","volume":"8","author":"Delli Bovi","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ejphar.2025.177890_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1388-1981(00)00140-2","article-title":"Regulation of gene expression by SREBP and SCAP","volume":"1529","author":"Edwards","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.177890_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","article-title":"Stratum corneum defensive functions: an integrated view","volume":"125","author":"Elias","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177890_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12906-019-2671-9","article-title":"Diosgenin ameliorates palmitic acid-induced lipid accumulation via AMPK\/ACC\/CPT-1A and SREBP-1c\/FAS signaling pathways in LO2 cells","volume":"19","author":"Fang","year":"2019","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.ejphar.2025.177890_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.niox.2009.09.004","article-title":"Resveratrol attenuates lipopolysaccharide-induced hepatitis in D-galactosamine sensitized rats: role of nitric oxide synthase 2 and heme oxygenase-1","volume":"21","author":"Farghali","year":"2009","journal-title":"Nitric Oxide :Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177890_bib16","first-page":"1919","article-title":"Fatostatin suppresses growth and enhances apoptosis by blocking SREBP-regulated metabolic pathways in endometrial carcinoma","volume":"39","author":"Gao","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2025.177890_bib17","doi-asserted-by":"crossref","first-page":"17001","DOI":"10.1074\/jbc.C116.737346","article-title":"Fatostatin inhibits cancer cell proliferation by affecting mitotic microtubule spindle assembly and cell division","volume":"291","author":"Gholkar","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177890_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.108.139626","article-title":"Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals","volume":"326","author":"Hawkins","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177890_bib19","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177890_bib20","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1073\/pnas.1534923100","article-title":"Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes","volume":"100","author":"Horton","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejphar.2025.177890_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?","volume":"96","author":"Imokawa","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2025.177890_bib22","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.bbadis.2015.08.018","article-title":"Fatostatin, an SREBP inhibitor, prevented RANKL-induced bone loss by suppression of osteoclast differentiation","volume":"1852","author":"Inoue","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.177890_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","article-title":"SREBPs: metabolic integrators in physiology and metabolism","volume":"23","author":"Jeon","year":"2012","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"key":"10.1016\/j.ejphar.2025.177890_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.177890_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.177890_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2025.177890_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.numecd.2018.12.001","article-title":"Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK","volume":"29","author":"Kim","year":"2019","journal-title":"Nutr. Metabol. Cardiovasc. Dis. : Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2025.177890_bib28","first-page":"1","article-title":"Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177890_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.ejphar.2025.177890_bib30","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.dsx.2020.09.026","article-title":"Pathophysiological mechanisms underlying MAFLD","volume":"14","author":"Kuchay","year":"2020","journal-title":"Diabetes Metabol. Syndr."},{"key":"10.1016\/j.ejphar.2025.177890_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2019.06.005","article-title":"The cytokine TNF promotes transcription factor SREBP activity and binding to inflammatory genes to activate macrophages and limit tissue repair","volume":"51","author":"Kusnadi","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2025.177890_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236612","article-title":"Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling","volume":"15","author":"La\u0111inovi\u0107","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177890_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2015.06.121","article-title":"Oxidative stress triggers lipid droplet accumulation in primary cultured hepatocytes by activating fatty acid synthesis","volume":"464","author":"Lee","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.177890_bib34","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.201700845R","article-title":"CREB\/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis","volume":"32","author":"Lee","year":"2018","journal-title":"FASEB J. : Off. Pub. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.ejphar.2025.177890_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110091","article-title":"Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor \u03b1 modulator-induced hepatic lipid accumulation","volume":"365","author":"Li","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2025.177890_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1535-7163.MCT-13-0797","article-title":"Fatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling","volume":"13","author":"Li","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2025.177890_bib37","article-title":"Key events in cancer: dysregulation of SREBPs","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177890_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2025.177890_bib39","article-title":"The potential role of transcription factor sterol regulatory element binding proteins (SREBPs) in Alzheimer's disease","volume":"180","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177890_bib40","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.2147\/DDDT.S253876","article-title":"Fatostatin in combination with tamoxifen induces synergistic inhibition in ER-Positive breast cancer","volume":"14","author":"Liu","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2025.177890_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/path.5130","article-title":"Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma","volume":"246","author":"Lo","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177890_bib42","first-page":"2965","article-title":"Apigenin reduces the excessive accumulation of lipids induced by palmitic acid via the AMPK signaling pathway in HepG2 cells","volume":"18","author":"Lu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.177890_bib43","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/bph.15369","article-title":"Ilexgenin A restrains CRTC2 in the cytoplasm to prevent SREBP1 maturation via AMP kinase activation in the liver","volume":"179","author":"Lu","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177890_bib44","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ptr.6582","article-title":"Scutellarin, a modulator of mTOR, attenuates hepatic insulin resistance by regulating hepatocyte lipid metabolism via SREBP-1c suppression","volume":"34","author":"Luan","year":"2020","journal-title":"Phytother Res. : PTR"},{"key":"10.1016\/j.ejphar.2025.177890_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/2211-5463.13364","article-title":"Fatostatin ameliorates inflammation without affecting cell viability","volume":"12","author":"Ma","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejphar.2025.177890_bib46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-021-03762-0","article-title":"Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-\u03baB pathway in endometrial carcinoma","volume":"12","author":"Ma","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177890_bib47","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1016\/j.celrep.2020.02.098","article-title":"The absence of HIF-1\u03b1 increases susceptibility to Leishmania donovani infection via activation of BNIP3\/mTOR\/SREBP-1c axis","volume":"30","author":"Mesquita","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177890_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The Scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2025.177890_bib49","series-title":"A Lipidomics-Based Approach to Study Fatostatin-Induced Toxicity","author":"Morrow","year":"2019"},{"key":"10.1016\/j.ejphar.2025.177890_bib50","doi-asserted-by":"crossref","first-page":"F614","DOI":"10.1152\/ajprenal.00140.2016","article-title":"SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction","volume":"311","author":"Mustafa","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2025.177890_bib51","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab166","article-title":"LH Induces De Novo Cholesterol Biosynthesis via SREBP Activation in Granulosa Cells During Ovulation in Female Mice","volume":"162","author":"Nakanishi","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2025.177890_bib52","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chemosphere.2018.10.058","article-title":"SREBP-1 and LXR\u03b1 pathways mediated Cu-induced hepatic lipid metabolism in zebrafish Danio rerio","volume":"215","author":"Pan","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.ejphar.2025.177890_bib53","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11745-016-4160-y","article-title":"Free fatty acids increase intracellular lipid accumulation and oxidative stress by modulating PPAR\u03b1 and SREBP-1c in L-02 cells","volume":"51","author":"Qin","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.ejphar.2025.177890_bib54","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.177890_bib55","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3168\/jds.2017-13171","article-title":"Short communication: circulating fatty acylcarnitines are elevated in overweight periparturient dairy cows in association with sphingolipid biomarkers of insulin resistance","volume":"101","author":"Rico","year":"2018","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.ejphar.2025.177890_bib56","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology (Baltimore, Md"},{"key":"10.1016\/j.ejphar.2025.177890_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","article-title":"Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells","volume":"375","author":"Sekiya","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.177890_bib58","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2015.04.010","article-title":"Targeting SREBPs for treatment of the metabolic syndrome","volume":"36","author":"Soyal","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.177890_bib59","doi-asserted-by":"crossref","first-page":"G844","DOI":"10.1152\/ajpgi.00200.2010","article-title":"Lipoprotein profiles in SCID\/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success","volume":"299","author":"Steenbergen","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2025.177890_bib60","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/s41467-018-04664-0","article-title":"Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy","volume":"9","author":"Talebi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2025.177890_bib61","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2025.177890_bib62","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1210\/en.2018-00093","article-title":"Inhibition of SREBP with fatostatin does not attenuate early diabetic nephropathy in Male mice","volume":"159","author":"Van Krieken","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2025.177890_bib63","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcmgh.2023.02.010","article-title":"Hepatic Stellate cells: dictating outcome in nonalcoholic fatty liver disease","volume":"15","author":"Wiering","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2025.177890_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/abbs\/gms112","article-title":"SREBP: a novel therapeutic target","volume":"45","author":"Xiao","year":"2013","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejphar.2025.177890_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41420-021-00744-1","article-title":"Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer","volume":"7","author":"Xu","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.177890_bib66","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","article-title":"Targeting SREBP-2-Regulated mevalonate metabolism for cancer therapy","volume":"10","author":"Xue","year":"2020","journal-title":"Front. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2025.177890_bib67","first-page":"S186","article-title":"A high-fat diet reduces ceramide synthesis by decreasing adiponectin levels and decreases lipid content by modulating HMG-CoA reductase and CPT-1 mRNA expression in the skin","volume":"55","author":"Yamane","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2025.177890_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108327","article-title":"Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism","volume":"684","author":"Yao","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2025.177890_bib69","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/path.5530","article-title":"ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p","volume":"252","author":"Yu","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177890_bib70","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2337\/db13-0835","article-title":"Inhibition of SREBP transcriptional activity by a boron-containing compound improves lipid homeostasis in diet-induced obesity","volume":"63","author":"Zhao","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2025.177890_bib71","article-title":"The Nrf2 pathway in liver diseases","volume":"10","author":"Zhou","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.177890_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176519","article-title":"Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes","volume":"971","author":"Zhu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177890_bib73","doi-asserted-by":"crossref","unstructured":"Kamei, Y., Miura, S., Suganami, T., Akaike, F., Kanai, S., Sugita, S., Katsumata, A., Aburatani, H., Unterman, T.G., Ezaki, O., Ogawa, Y., 2008. Regulation of SREBP1c gene expression in skeletal muscle: Role of retinoid X receptor\/liver X receptor and forkhead-O1 transcription factor. Endocrinology 149 (5): 2293\u20132305. https:\/\/doi.org\/10.1210\/en.2007-1461.","DOI":"10.1210\/en.2007-1461"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925006442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:29:08Z","timestamp":1762144148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925006442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":73,"alternative-id":["S0014299925006442"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177890","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of the SREBP1\/2 inhibitor, fatostatin, in a preclinical model of metabolic dysfunction-associated steatotic liver disease progression","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177890"}}